Materials NanoScience
Keywords: item categories
DNA nanotechnology has become a programmable platform for building precise nanoscale architectures with applications across biomedicine and materials science. This review examines recent advances in the design, synthesis and biological evaluation of DNA nanomaterials, including DNA origami, tetrahedral DNA nanostructures and DNA hydrogels. We survey established and emerging fabrication routes, among them chemical synthesis, enzymatic methods, hybridization, microfluidics and machine learning-guided design, and what each offers for scalability and cost. Structural strategies such as scaffold-staple folding are reviewed alongside surface chemistries including PEGylation and lipid bilayer encapsulation, with attention to their effect on stability and biological efficacy. Behavior in vivo is covered in detail: nuclease-mediated degradation, intracellular trafficking, clearance, and the biological interactions set by protein corona formation and physicochemical properties. For targeted therapeutics we cover aptamer functionalization and aptamer-drug conjugates; for molecular diagnostics, aptamer-based electrochemical biosensing and point-of-care formats. Immunogenicity and safety are treated in detail, including innate immune stimulation through TLR9 and cGAS-STING, complement activation and cytotoxicity. By setting out the preclinical evaluation frameworks that matter, among them pharmacokinetic characterization and toxicity testing, the review connects design decisions to biological safety and to what clinical translation of DNA nanomedicines will require.
Discover more from RSYN FYI
Subscribe to get the latest posts sent to your email.